Oncolytics Biotech
$0.00 (0.00%) As of 1:59 PM UTC pre-market
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ONCY and other ETFs, options, and stocks.
About ONCY
Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses.
CEO
Matthew C. Coffey
Employees
25
Headquarters
Calgary, Alberta
Founded
1998
ONCY Key Statistics
Market cap
88.04M
Price-Earnings ratio
—
Dividend yield
—
Average volume
299.65K
High today
$1.64
Low today
$1.55
Open price
$1.64
Volume
245.64K
52 Week high
$4.83
52 Week low
$1.55
ONCY Earnings
-$0.17
-$0.11
-$0.06
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 4, Pre-Market